Fosun Pharma (600196.SH) Holding Subsidiary Receives Acceptance of Drug Registration Application.

Judiciary Finance APP News, Fosun Pharma (600196.SH) announced that its controlling subsidiary, Jingisame (Wuhan) Pharmaceutical Co., Ltd., recently had its registration application for the drug injection Neptelptin accepted by the National Medical Products Administration.